CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
September 2016—Streck and Biodesix, a molecular diagnostics company that develops blood-based tests in oncology, have signed an agreement to make Streck the exclusive supplier of DNA and RNA tubes for Biodesix.
In a separate announcement, Streck and Conversant Bio, a biotechnology company that partners with physician clinics, hospitals, and clinical research sites to provide diseased and normal tissue specimens to researchers, have signed an exclusive worldwide supply agreement.
Biodesix and Conversant Bio will utilize Streck’s technology, including its blood collection tubes, as part of its respective products and services. Streck’s blood collection tubes include Cell-Free DNA BCT and Cell-Free RNA BCT.
Streck, 800-843-0912